UY Scuti Acquisition Corp. (UYSC)

UY Scuti Acquisition Corp. is a special purpose acquisition company, or blank-check company, formed to complete a merger, share exchange or similar business combination with one or more operating businesses. It completed its initial public offering on Nasdaq in 2025, and the proceeds are held in a trust account pending a transaction.

The company has said it intends to focus on middle-market growth businesses, while not restricting its search to a specific industry. Its chief executive, Jialuan Ma, previously held a senior finance role at Roche Pharma China.

The SPAC is based in New York. Like other blank-check companies, it has no operations or revenue of its own, and shareholders may redeem their shares for a share of the trust account in connection with a proposed business combination.